Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jul 9, 2023
Open Peer Review Period: Jul 9, 2023 - Sep 3, 2023
Date Accepted: Jun 12, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Estimating global and regional burden of Streptococcus Pneumoniae meningitis in children: a protocol for a systematic review and meta-analysis
ABSTRACT
Background:
Streptococcus Pneumoniae (Spn) has been a leading cause of bacterial meningitis in children. The most recent estimation on the global burden of Spn meningitis reports a positive trajectory in eliminating Spn through implementing pneumococcal conjugate vaccines (PCV). However, continuous monitoring and assessment of the disease burden is necessary due to the evidence of serotype replacement, antibiotic resistance, and impact of the recent coronavirus disease 2019 (COVID-19) pandemic.
Objective:
Therefore, the aim of this systematic review is to provide an updated protocol on the global and regional burden of Spn meningitis in children which can guide policies and strategies to reduce the disease burden.
Methods:
Population-based studies from 01 Jan 2000 to 01 Jan 2022 from electronic databases PubMed, Embase, Global Health (CABI), and Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus will be searched without any language restrictions. Generalised linear mixed models (GLMMs) meta-analysis will be performed to estimate pooled incidence and case-fatality-ratio. We will further assess risk of bias, heterogeneity, and perform subgroup and sensitivity analysis to provide meaningful interpretation of the current burden and literature for pneumococcal meningitis.
Results:
Ethical approval from an ethics committee will not be required as this review will only include published data. The results from this study will be disseminated through conferences and published in a peer-reviewed journal.
Conclusions:
. Clinical Trial: This review has been registered with the International Prospective Register of Systematic Reviews (PROSPERO) – CRD42021293110
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.